The nurse is performing the resident's medication reconciliation on admission to the long-term care facility. The nurse recognizes the resident has a history of gout after seeing that the resident is taking which two medications? (Select all that apply.)

A. Metoprolol: Metoprolol is a beta-blocker used for hypertension, heart failure, or arrhythmias. It has no role in the treatment or prevention of gout and does not indicate a history of this condition. B. Allopurinol: Allopurinol is a xanthine oxidase inhibitor that lowers serum uric acid levels and is used for long-term management of gout to prevent flares and urate crystal deposition. Its presence strongly suggests a history of gout. C. Colchicine: Colchicine is used to treat acute gout attacks and prevent recurrent flares. The use of colchicine indicates that the resident has experienced gout episodes in the past or is at risk for flares. D. Etanercept: Etanercept is a TNF inhibitor used for rheumatoid arthritis and other autoimmune conditions. It is unrelated to gout management and does not indicate a history of gout. E. Clopidogrel: Clopidogrel is an antiplatelet medication used to prevent thrombotic events, such as stroke or myocardial infarction. It has no therapeutic role in gout and does not suggest a history of the disease. F. Ibandronate: Ibandronate is a bisphosphonate used for osteoporosis to prevent bone loss. It is not used for gout treatment or prevention and does not indicate a history of gout.